Written by: Dr. Akash Chandawarkar, Board Certified Plastic Surgeon, Mirror Plastic Surgery | Last updated: September 9, 2026
Key Takeaways
- GLP-1 peptide amounts are highly individualized and follow structured titration schedules to minimize side effects while supporting results.1
- Knowing the difference between milligrams, milliliters, and syringe units helps you avoid dosing errors that can cause serious complications.
- Compounded GLP-1 peptides carry added risks such as contamination, incorrect potency, and labeling issues that call for medical oversight.
- Starting at low doses and increasing gradually lets your body adapt and lowers the chance of severe gastrointestinal side effects.
- Work with a provider who offers personalized, medically supervised GLP-1 protocols tailored to your labs, physiology, and goals.
What GLP-1 Is And How It Affects Your Body
GLP-1 (glucagon-like peptide-1) is a natural hormone that regulates appetite, slows stomach emptying, and triggers insulin release when blood sugar rises. GLP-1 receptor agonists are synthetic versions designed to last longer in your body. Clinicians use them for type 2 diabetes management and for weight loss in adults with obesity or overweight plus a weight-related condition.
The amount you take matters because these medications have a narrow therapeutic window. Insufficient doses produce little benefit, while excessive doses can cause severe nausea, vomiting, and diarrhea that may require hospitalization. Every FDA-approved GLP-1 follows a structured titration schedule so your digestive system can adjust step by step.
FDA-Approved GLP-1 Medications And Typical Doses
Four GLP-1 receptor agonists dominate the U.S. market: semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity). Each has a specific dosing pattern established through large clinical trials.
| Medication | Starting Dose | Titration Schedule | Maximum Dose |
|---|---|---|---|
| Semaglutide (Wegovy) | 0.25 mg weekly | Increase every 4 weeks: 0.25 → 0.5 → 1.0 → 1.7 mg | 2.4 mg weekly (maintenance from week 17); 7.2 mg weekly for Wegovy HD, approved March 2026 |
| Tirzepatide (Zepbound) | 2.5 mg weekly | Increase by 2.5 mg every 4 weeks as tolerated | 15 mg weekly |
| Liraglutide (Saxenda) | 0.6 mg daily | Increase weekly: 0.6 → 1.2 → 1.8 → 2.4 mg | 3.0 mg daily (from week 5) |
| Dulaglutide (Trulicity) | 0.75 mg weekly | Increase every 4 weeks: 0.75 → 1.5 → 3.0 mg; at least 4 weeks at 3.0 mg before increasing to 4.5 mg | 4.5 mg weekly |
Dulaglutide is FDA-approved for type 2 diabetes and cardiovascular risk reduction, not weight loss. Wegovy HD, a higher-dose semaglutide at 7.2 mg weekly, received FDA approval in March 2026 for weight management. Higher doses continue to be studied under strict regulatory oversight.
Individual responses vary widely. The 2022 American Gastroenterological Association guideline recommends checking progress at 12–16 weeks. Losing at least 5% of starting body weight signals a strong response and often supports staying at the current dose. Your clinician may adjust based on side effects, blood sugar trends, or weight changes.
Schedule A GLP-1 Consultation With Ellie to discuss a protocol based on your labs, physiology, and goals.
How To Read A GLP-1 Prescription: mg, mL, And Units
Three measurement systems show up on GLP-1 prescriptions, and mixing them up creates serious risk.
- Milligrams (mg): The mass of the active drug. Your prescribed dose uses this unit.
- Milliliters (mL): The volume of liquid in your vial or pen.
- Units: The markings on a U-100 insulin syringe, where 100 units equals 1 mL.
The core conversion uses three steps.
- Determine your vial’s concentration: Total mg in vial ÷ Total mL of liquid = mg per mL.
- Calculate your injection volume: Prescribed dose (mg) ÷ Concentration (mg/mL) = mL to inject.
- Convert to syringe units: mL × 100 = units on a U-100 insulin syringe.
Worked example A: A 5 mg vial of semaglutide mixed with 2 mL of bacteriostatic water gives 2.5 mg/mL. A 0.25 mg starting dose equals 0.1 mL, which is 10 units on a U-100 insulin syringe.
Worked example B: A 10 mg vial mixed with 1 mL of water gives 10 mg/mL. A 0.5 mg dose equals 0.05 mL, or 5 units. At 10 mg/mL, every milligram converts to exactly 10 units, which keeps the math simple and helps reduce mistakes.
How many units is 1 mL for peptides? On a U-100 insulin syringe, 1 mL always equals 100 units. The actual milligram dose still depends on your vial’s concentration.
How much will 10 mg of peptides last? At a 2.5 mg weekly starting dose of tirzepatide, a 10 mg vial lasts 4 weeks. At a 0.25 mg weekly starting dose of semaglutide, the same vial could theoretically last 40 weeks, although most multi-dose vials carry a 28-day discard date after first puncture per USP 797 guidelines.
The FDA has received multiple reports of adverse events, some requiring hospitalization, linked to dosing errors with compounded injectable semaglutide. Some patients drew five to twenty times their intended dose by treating syringe volume markings as milligrams.
Compounded GLP-1 Peptides: Safety And Dosing Risks
Compounded GLP-1 peptides are custom-made versions of drugs like semaglutide or tirzepatide, often sold as powder vials that you mix at home. These products are not FDA-approved and do not go through the same quality checks as brand-name medications.
The FDA has documented significant risks with compounded GLP-1s, including:
- Dosing errors: Patients measuring wrong amounts, sometimes 5–20 times the intended dose
- Contamination and sterility failures: Multiple recalls for lack of sterility assurance
- Fraudulent labeling: Products with labels naming pharmacies that do not exist
- Unknown potency: Vials that contain more or less active ingredient than labeled
- Salt forms: Use of semaglutide sodium or acetate, which differ from the FDA-approved ingredient and have unknown safety profiles
As of May 31, 2026, the FDA had received 990 adverse event reports associated with compounded semaglutide and more than 730 associated with compounded tirzepatide. These figures likely underestimate true events because many state-licensed pharmacies are not required to report.
If you use compounded peptides, choose a prescription from a licensed provider, a pharmacy that performs batch testing, clear mixing and dosing instructions, and a beyond-use date of 28 days or less after first puncture. Even the most careful compounding pharmacy cannot match FDA manufacturing controls, so medical supervision remains essential.
Why GLP-1 Titration Starts Low And Goes Slow
Titration, which means starting low and increasing gradually, exists to limit gastrointestinal side effects while your body adapts. The initial doses of GLP-1 medications are intentionally below full therapeutic strength.
For semaglutide (Wegovy), the FDA-approved schedule spans 16 weeks: 0.25 mg for weeks 1–4, 0.5 mg for weeks 5–8, 1.0 mg for weeks 9–12, 1.7 mg for weeks 13–16, then 2.4 mg as the maintenance dose from week 17 onward.
For tirzepatide (Zepbound), the schedule is 2.5 mg for weeks 1–4 (initiation only, not intended for glycemic control), then 5 mg, with 2.5 mg increases every 4 weeks as tolerated, up to 15 mg.
Skipping titration steps or increasing too quickly creates real danger. The FDA has received reports of patients prescribed compounded semaglutide or tirzepatide in doses beyond approved labels, including larger amounts per dose, more frequent injections, or faster escalation. Some patients needed care for severe nausea, vomiting, diarrhea, and abdominal pain.
Real-world data from obesity clinics shows that only about 23% of semaglutide users and 28% of tirzepatide users ever reach the maximum dose. Many people meet their goals at middle doses. The purpose of titration is to find the lowest effective dose, rather than racing to the top of the range.
Common GLP-1 Dosing Mistakes And How To Avoid Them
Several predictable errors show up repeatedly in GLP-1 dosing, and understanding them helps you stay safe.
One common error is confusing milligrams with milliliters. A milligram measures drug mass, while a milliliter measures liquid volume. Drawing 0.5 mL when your dose is 0.5 mg can deliver ten times your intended amount, depending on your vial’s concentration.
Another frequent mistake is using the wrong syringe. U-100 insulin syringes are standard, but U-500 syringes also exist. Using a U-500 syringe delivers five times the intended dose per unit drawn. The FDA documented 14 cases of patients using U-500 syringes for compounded semaglutide, all resulting in significant underdosing.
Timing mistakes also matter. GLP-1 medications have long half-lives, about 7 days for semaglutide and 5 days for tirzepatide. Doubling up after a missed dose can cause drug levels to build up and trigger severe side effects.
Concentration changes create another risk. If your pharmacy switches your vial from 5 mg/mL to 10 mg/mL and you keep drawing the same number of units, you receive double your intended dose. A 2025 analysis of the FDA MedWatch database found that concentration errors account for 62% of compounded GLP-1 dosing mistakes.
Storage and expiration issues round out the list. Reconstituted GLP-1 vials should be discarded 28 days after first puncture. The FDA specifically warns against using injectable GLP-1 drugs that arrive without proper refrigeration.
Use these practical steps to protect yourself:
- Double-check the vial label before every injection
- Use a new syringe for each dose
- Write down your dose in milligrams and recalculate units whenever you receive a new vial
- Confirm your vial’s concentration with your prescribing clinician before using any new shipment
- Contact your provider before injecting if anything seems unclear
Request GLP-1 Dosing Guidance From Ellie to review your reconstitution steps and injection plan with clear, step-by-step support.
When To Talk To A Doctor About GLP-1 Dosing
Professional guidance becomes crucial once you move from general information to your specific dose. Determining the right GLP-1 peptide amount requires a full review of your medical history, current medications, lab results, and goals. This level of oversight matters even more with compounded peptides, where dosing flexibility and product variability increase the chance of error.
If you are considering GLP-1 therapy, look for a provider who offers comprehensive lab testing, personalized dosing plans, and close follow-up. At Mirror Plastic Surgery, Dr. Akash Chandawarkar, a board-certified plastic surgeon with training from Harvard Medical School and Johns Hopkins, provides medically supervised GLP-1 protocols. Each patient receives an in-depth consultation that may include broad lab panels to uncover metabolic issues, and peptides come from vetted suppliers with rigorous batch testing.
Mirror Plastic Surgery focuses on concierge-style care. You receive direct access to Dr. Chandawarkar via text, detailed instructions for reconstitution and self-administration, and ongoing support throughout treatment. The practice limits daily volume so each patient receives focused, unhurried attention.
Arrange A Personalized Peptide Consultation to explore whether a tailored GLP-1 protocol fits your health and aesthetic goals.
Frequently Asked Questions
Is 2.5 mg Of GLP-1 A Lot?
Context determines whether 2.5 mg is appropriate. For tirzepatide (Zepbound or Mounjaro), 2.5 mg is the standard starting dose. It is deliberately sub-therapeutic and used only for the first four weeks so your digestive system can adapt. For semaglutide, 2.5 mg equals roughly ten times the 0.25 mg starting dose and can cause intense gastrointestinal symptoms. The same milligram amount can be safe or risky depending on the medication and your place in the titration schedule. Always compare doses within the same drug and follow a licensed clinician’s guidance.
How Many Units Is 1 mL For Peptides?
On a U-100 insulin syringe, 1 mL equals 100 units, as explained earlier. The key detail is that the milligram amount still depends on your vial’s concentration. A 1 mL draw from a 2.5 mg/mL vial delivers 2.5 mg, while 1 mL from a 10 mg/mL vial delivers 10 mg. Always verify the concentration label and recalculate from scratch whenever you receive a new vial, even from the same pharmacy.
How Much Will 10 mg Of Peptides Last?
Duration depends on the specific drug and your prescribed dose. A 10 mg vial of tirzepatide at the 2.5 mg starting dose lasts 4 weeks, and at 5 mg it lasts 2 weeks. For semaglutide at 0.25 mg weekly, a 10 mg vial could theoretically last 40 weeks, but remember the 28-day discard rule mentioned earlier applies. Liraglutide, which is dosed daily, would use a 10 mg vial in about 5–6 days at a 1.8 mg daily dose. Always factor in the beyond-use date as well as the math.
Can You Take Too Much GLP-1?
Taking more GLP-1 than prescribed can cause severe nausea, vomiting, diarrhea, dehydration, and sometimes hospitalization. As noted earlier, the FDA has documented cases of patients taking 5–20 times their intended dose, often due to drawing errors with compounded products. Skipping titration steps carries similar risk, and accelerated schedules in real-world studies show discontinuation rates of 10–15% from intolerable side effects. Never increase your dose or repeat a missed dose without medical supervision.
What Makes Mirror Plastic Surgery Different From A Telehealth GLP-1 Clinic?
Most high-volume telehealth platforms issue a prescription and ship a vial with limited follow-up. Mirror Plastic Surgery operates on a concierge medicine model. Dr. Akash Chandawarkar spends up to an hour in consultation, reviews comprehensive lab panels (thyroid, liver, kidney, diabetes, and hormone markers), and then designs a protocol around your specific physiology.
Peptides come from reputable providers with strict batch testing. Patients receive direct 24/7 text access to Dr. Chandawarkar for questions, refill coordination, and dose adjustments, which supports safer and more effective therapy.
The Right GLP-1 Amount Under The Right Supervision
GLP-1 peptide amounts work best when they are precise and individualized. FDA-approved medications use structured titration schedules to balance results with tolerability. Compounded peptides demand even more caution because of dosing flexibility and product variability.
Keep these points in mind:
- Each GLP-1 medication has its own starting dose, titration schedule, and maximum dose.
- Milligrams measure drug mass, milliliters measure volume, and syringe units form a third system that you must convert correctly.
- Compounded peptides introduce extra risks that call for professional oversight.
- Titration protects you by allowing your body to adapt gradually to higher doses.
- The ideal maintenance dose is the lowest one that meets your goals with manageable side effects.
Mirror Plastic Surgery offers personalized, medically supervised peptide therapy with Dr. Akash Chandawarkar. Every protocol reflects your labs, physiology, and goals, supported by concierge-level follow-up. Start Your GLP-1 Evaluation With Ellie by text or call at 727-361-6515, email [email protected], or visit the St. Petersburg office at 780 4th Ave S.
This article is for educational purposes and does not replace professional medical advice. Consult a licensed physician before starting any peptide therapy.
1 Results may vary from person to person. Editorial content, before and after images, and patient testimonials do not constitute a guarantee of specific results.
Peptide therapy is intended for wellness and optimization purposes and is not prescribed to diagnose, treat, cure, or prevent disease unless specifically stated. Many peptides are not FDA-approved and may be used off-label. Some have limited long-term safety data, with a potential for unknown risks, complications, or desensitization with prolonged use.
